Adeola Adeyeye

机构：Stony Brook University Hospital, National Institute of Allergy and Infectious Diseases, James Paget University Hospitals NHS Foundation Trust · ORCID：0000-0002-3677-6068

发表论文 50 篇 · 总被引 2750 次 · h-index 19

代表论文

• Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial (2023 · The Lancet HIV · 被引 70)
• Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis (2024 · New England Journal of Medicine · 被引 37)
• Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study (2024 · The Lancet HIV · 被引 30)
• Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 (2023 · Antimicrobial Agents and Chemotherapy · 被引 30)
• Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study (2024 · The Lancet HIV · 被引 26)
• High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial (2023 · Sexually Transmitted Infections · 被引 26)